Search Within

GDMT, Medicine

Formats
  1. Journal Article (935)
  2. Meeting Abstract (836)
  3. Review (49)
  4. Book Section (38)
  5. Editorial (30)
  6. Guidelines (19)
  7. Correspondence (7)
  8. Research Letter (1)
Groups
  1. Gynecology Disease Management Team (1915)
  2. Department of Medicine (1904)
  3. Solid Tumor Oncology Division (1904)
  4. Gynecologic Medicine Service (1864)
  5. Surgery (585)
  6. GDMT, Surgery (467)

More Groups

People
  1. Carol Aghajanian (616)
  2. Martee Hensley (290)
  3. Nadeem Abu-Rustum (281)
  4. Roisin O'Cearbhaill (275)
  5. Vicky Makker (270)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (78)
  2. 2024 (159)
  3. 2023 (165)
  4. 2022 (196)
  5. 2021 (146)
  6. 2020 (173)

More Years

Publications
  1. Journal of Clinical Oncology (421)
  2. Gynecologic Oncology (419)
  3. International Journal of Gynecological Cancer (156)
  4. Annals of Oncology (107)
  5. Clinical Cancer Research (65)
  6. Cancer (37)

More Publications

Publishers
  1. American Society of Clinical Oncology (453)
  2. Elsevier B.V. (443)
  3. Lippincott Williams & Wilkins (181)
  4. American Association for Cancer Research (141)
  5. Oxford University Press (130)
  6. Elsevier Inc. (83)

More Publishers

Results (1915)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T cell intrinsic DNA damage and repair response as a novel marker associated with clinical response to PD-1 blockade
    Meeting Abstract

    Muroyama, Y.; Manne, S.; Greenplate, A.; Mathew, D.; Oldridge, D.; Chilukuri, L.; Xu, C.; Herati, R.; Huang, A.; Zamarin, D.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Tisotumab vedotin (TV) + bevacizumab or pembrolizumab or carboplatin in recurrent/metastatic cervical cancer (r/mCC): Phase 1b/2 ENGOT-cx8/GOG-3024/ innovaTV 205 study dose-escalation results
    Meeting Abstract

    Monk, B.; Van Gorp, T.; Lorusso, D.; O'Cearbhaill, R. E.; Westermann, A.; Banerjee, S.; Collins, D.; Klat, J.; Madsen, K.; Baurain, J. F.; more...
    International Journal of Gynecological Cancer (2021)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling of low-grade serous cancers and associated clinical outcomes
    Meeting Abstract

    Manning-Geist, B.; Gordhandas, S.; Da Cruz Paula, A.; Weigelt, B.; Liu, Y.; Chui, H.; Grisham, R.
    International Journal of Gynecological Cancer (2021)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian cancer (HGOC)
    Meeting Abstract

    Coleman, R. L.; Oza, A.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J.; Clamp, A.; Scambia, G.; more...
    International Journal of Gynecological Cancer (2021)

    Fulltext@MSK | Save
  • Randomized phase 3 study of lenvatinib plus pembrolizumab for advanced endometrial cancer (aEC): Subgroup analysis of patients with DNA mismatch repair deficient (DMMR) tumors
    Meeting Abstract

    Makker, V.; Colombo, N.; Casado Herráez, A.; Santin, A.; Colomba, E.; Miller, D.; Fujiwara, K.; Pignata, S.; Banerjee, S.; Monk, B.; more...
    International Journal of Gynecological Cancer (2021)

    Fulltext@MSK | Save
  • A multicenter, open-label, randomized, phase 3 study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab vs treatment of physician's choice in patients with advanced endometrial cancer: Study 309/Keynote-775
    Meeting Abstract

    Makker, V.; Colombo, N.; Casado Herráez, A.; Santin, A.; Colomba, E.; Miller, D.; Fujiwara, K.; Pignata, S.; Baron-Hay, S.; Ray-Coquard, I.; more...
    International Journal of Gynecological Cancer (2021)

    Fulltext@MSK | Save
  • A comprehensive comparison of early-onset and average-onset colorectal cancers
    Journal Article

    Cercek, A.; Chatila, W. K.; Yaeger, R.; Walch, H.; Dos Santos Fernandes, G.; Krishnan, A.; Palmaira, L.; Maio, A.; Kemel, Y.; Srinivasan, P.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Phase I dose escalation study of MCLA-145, a bispecific antibody targeting CD137 and PD-L1 in solid tumors
    Meeting Abstract

    Prenen, H.; Kyi, C.; Van Lancker, G.; Patel, S. P.; Mittag, D.; Weaver, A.; Bol, K.; Stalbovskaya, V.; Pulini, J.; Zhou, G.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor
    Meeting Abstract

    Adusumilli, P. S.; Amador, A. M.; Chintala, N.; Hou, Z.; Offin, M.; Pineda, J.; Senechal, B.; Quach, H. T.; Bellis, R.; Banerjee, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Frequency of colorectal neoplasia in young onset colorectal cancer does not warrant shorter surveillance intervals
    Meeting Abstract

    Mendelsohn, R.; Hahn, A.; Palmaira, R. L.; Krishnan, A. R.; Lumish, M.; Schattner, M.; Markowitz, A.; Ludwig, E.; Shah, P.; Calo, D.; more...
    American Journal of Gastroenterology (2021)

    Fulltext@MSK | Save